Sunday, September 21, 2008
Sunday, September 14, 2008
Childhood Cancer Awareness Day
Childhood Cancer Awareness DayBy Mommy to those Special Ks(Mommy to those Special Ks) Today, September 13th is National Childhood Cancer Awareness Day. Children all over the country are dying every day from cancer. Those that live deal with life long effects from chemo. Every day. Cancer does not discriminate against ...Life With My Special Ks - http://www.myspecialks.com/
Thursday, September 11, 2008
CT scan images of colorectal cancer
Please look through the link to see some CT images of colorectal cancer and links to information pages on http://www.catscanman.net/blog/2008/09/ct-in-colorectal-cancer-5/ Colorectal Cancer
Monday, September 8, 2008
Cancer news alert 9th September
Pallium IndiaVijayakumar, pancreatic cancer patient, was under the care Pallium India for more than four months before he expired at the end of April. He had to sell his property and house, on a mere five cents of land, to meet the treatment ...Care & Share - A non-profit 501(c)3... - http://careandsharenews.spaces.live.com/
See all stories on this topic Essential drugs become scarce in India, AfricaHindu Business Line - Chennai,India“For chronic diseases, there are reports of the industry willing to consider dual pricing so that poor people can access drugs f or cancer, diabetes, ...See all stories on this topic
See all stories on this topic Essential drugs become scarce in India, AfricaHindu Business Line - Chennai,India“For chronic diseases, there are reports of the industry willing to consider dual pricing so that poor people can access drugs f or cancer, diabetes, ...See all stories on this topic
Thursday, September 4, 2008
Actis acquires Cellpoint Diagnostics research assets
Actis Biologics (ABPL) has acquired the cancer drug discovery assets of US-based CellPoint Diagnostics for an undisclosed amount.
ABPL and its US parent, Actis Biologics, acquired about 15 patents and related assets for the technology platform Ligand Linker Drug Delivery (LLD) system, which can revolutionise chemotherapy for cancers with specific target therapy and less toxicity.
Read the news
ABPL and its US parent, Actis Biologics, acquired about 15 patents and related assets for the technology platform Ligand Linker Drug Delivery (LLD) system, which can revolutionise chemotherapy for cancers with specific target therapy and less toxicity.
Read the news
Subscribe to:
Posts (Atom)